Author

W. Wolf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. J. Hickey· 1 shared A. Schaefer· 1 shared C. Kim· 1 shared H. Aurora· 1 shared H. Kang· 1 shared I. Stewart· 1 shared J. Hutchins· 1 shared J. M. Cho· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. J. Hickey

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Stable nebulization and muco-trapping properties of Regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19

M. D. McSweeney, I. Stewart, Z. Richardson, H. Kang, Y. Park, C. Kim, K. Tiruthani, W. Wolf, A. Schaefer, P. Kumar, H. Aurora, J. Hutchins, J. M. Cho, A. J. Hickey, S. Y. Lee, S. K. Lai

This paper demonstrates that IN-006, a reformulated Regdanvimab, effectively traps SARS-CoV-2 virus-like particles in human airway mucus and achieves higher lung concentrations in rats when nebulized compared to intravenous delivery.

bioRxiv · Feb 27, 2022Bioengineering